NCT03479489
Completed
Not Applicable
A Prospective Case Series for Closed Hemorrhoidectomy - Efficacy of External Hemorrhoid Repair Using a Dehydrated Human Amnion Chorion Membrane
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- External Hemorrhoid
- Sponsor
- MiMedx Group, Inc.
- Enrollment
- 11
- Locations
- 1
- Primary Endpoint
- Reported Patient Pain
- Status
- Completed
- Last Updated
- 6 years ago
Overview
Brief Summary
The purpose of this study is to determine the safety and effectiveness of human dehydrated amnion chorion allograft in closed hemorrhoidectomy as assessed by patient and wound assessments.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Confirmed diagnosis of acutely thrombosed hemorrhoid or an external hemorrhoid exceeding 72 hours in duration
- •Subject is undergoing closed hemorrhoidectomy as their definitive treatment for the Grade 2-4 hemorrhoid
- •Subject is age 18 or older
- •Subject is willing and able to provide informed consent and participate in all procedures and follow-up evaluations necessary to complete the study
Exclusion Criteria
- •Subject has a known history of poor compliance with medical treatments
- •Subject has signs and symptoms of active cirrhosis
- •Subject has signs and symptoms of Crohn's disease complicated by perianal manifestations
- •Subject is currently taking immunosuppressive medications
- •Subject has had previous surgery in the target area within the past 6 months prior to treatment or plans to have surgery other than closed hemorrhoidectomy in the target area within 180 days of treatment
- •Subject is currently receiving radiation therapy or chemotherapy
- •Subject has used an investigational drug, device or biologic within 12 weeks prior to treatment
- •Subject is pregnant at enrollment or is planning to become pregnant within 180 days of treatment; subject intends to breastfeed during the course of the trial
- •Subject has any significant medical condition(s) that, in the opinion of the Investigator, would interfere with protocol evaluation and participation
- •Subject has an allergy or known sensitivity to aminoglycoside antibiotics such as gentamicin sulfate and/or streptomycin sulfate
Outcomes
Primary Outcomes
Reported Patient Pain
Time Frame: 60 days
The primary endpoint of the study is the change in patient reported pain across four categories from baseline within the 60 day follow-up period. In every patient diary, subjects will be asked to assess their pain on a 10 point Likert scale under the following conditions * Do you experience pain continuously? * Do you experience pain with activity? * Do you experience pain while sitting? * Do you experience pain with bowel movements?
Study Sites (1)
Loading locations...
Similar Trials
Completed
Not Applicable
Case Series of Weekly Applications of dHACM in Treatment of Pressure UlcersPressure UlcerNCT02861560MiMedx Group, Inc.10
Completed
Not Applicable
A Single Center, Prospective, Case Series of the Treatment of Pressure Ulcers and Decubitus Ulcers.Pressure UlcerNCT03529578MiMedx Group, Inc.20
Completed
Not Applicable
Use of dHACM in the Treatment of Venous Leg UlcersLeg UlcerNCT02011503MiMedx Group, Inc.128
Active, not recruiting
Phase 2
Human Amnion Membrane Allograft and Early Return of Erectile Function After Radical ProstatectomyProstate CancerErectile Dysfunction Following Radical ProstatectomyNCT05842057University of Miami118
Recruiting
Not Applicable
Dehydrated Human Amnion Membrane and Standard of Care Versus Standard of Care Alone in Nonhealing Diabetic Foot UlcersDiabetic FootUlcer FootFoot UlcerDiabetic Foot UlcerNCT06550596Axolotl Biologix100